City Therapeutics
CTY · NASDAQ
CTY key statistics
- Market cap
- —
- Price-earnings ratio
- —
- Dividend yield
- —
- Average volume
- 1.41M
- Volume
- 535.31K
- Open price
- $21.44
- High today
- $21.50
- Low today
- $20.00
- 52 Week high
- $23.88
- 52 Week low
- $20.50
City Therapeutics (CTY) at a glance
As of Oct 20, 2026, City Therapeutics (CTY) shares are priced at $20.52.
Today the stock has traded between $20.00 and $21.50. The current price is 2.6% above the day's low and 4.6% below its high.
Volume so far is 535.31K shares, below the average of 1.41M shares a day.
Over the past year City Therapeutics has ranged from $20.50 to $23.88, and now sits 1% of the way up that range.
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0005+150.00%
- NWGLCL Workshop Group$0.1331+11.85%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007−7.14%
- FITYFifty 1 Labs$0.0001−66.67%
- CBDW1606$0.0003+50.00%
- PRSOPeraso$0.5668+47.72%
- FRTTFort Technology$0.6963+29.69%
- CBDLCBD Life Sciences$0.0002+0.00%
- WFFWF Holding$0.0913−5.49%
- NBNDNetBrands$0.001−14.16%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.54+1.35%
- IAMIambic Therapeutics$15.42−5.63%
- AMROAmaero$5.75+2.50%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.27−0.19%
- TRXBTRex Bio$14.70−0.68%
- RTSNRetension Pharmaceuticals$16.56+1.41%
- PAXGUPine Tree Acquisition$9.99+0.10%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.28−1.68%
- RZAIROZE AI$10.22+0.69%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.